With Scrutiny Mounting and Billions at Stake, American Exchange Helps Providers Sustain 340B Savings Through PIAP and ACA Enrollment
The federal 340B Drug Pricing Program, launched in 1992, has enabled safety-net providers to stretch limited resources, purchase medications at reduced prices, and reinvest savings into patient care and community services. But today, the program is facing mounting legal, regulatory, and financial pressure that could reshape its future.
Source: Hospitalogy. “The 340B Breakdown,” December 5, 2024
https://hospitalogy.com/articles/2024-12-05/340b-breakdown/?utm_source=chatgpt.com
If you’re a covered entity relying on 340B revenue to fund services, you need to understand the latest developments—and act fast to adapt.
A Quick Look at 340B’s Scale
-
Over 50,000 covered entity sites participate nationwide
-
$54 billion in 340B-purchased drugs in 2022 alone
-
Many hospitals report 340B revenue accounts for up to 20% of their margin
-
Two-thirds of 340B hospitals operate at a loss without these savings
These numbers highlight the program’s critical importance—and the threat posed by new restrictions and scrutiny.
What’s Driving the Breakdown?
1. Manufacturer Pushback on Contract Pharmacies
More than 20 pharmaceutical companies have imposed limitations on 340B pricing at contract pharmacies, significantly reducing access to discounts and causing financial strain for providers.
2. Fragmented Oversight
HRSA oversees covered entities, but has no authority to enforce compliance among drug manufacturers, creating regulatory ambiguity and legal gridlock.
3. Political Pressure and Public Criticism
Critics claim some hospitals misuse 340B funds or don’t reinvest savings in underserved communities. Calls for reform may lead to stricter requirements, audits, or funding limits.
4. Funding Gaps and Medicaid Disenrollments
With Medicaid redeterminations resuming, many patients are losing coverage—cutting into the insured prescription volume that helps generate 340B savings.
The Solution: Enroll More Patients, Sustain More Savings
As the financial landscape grows more challenging, proactively enrolling patients into ACA Marketplace plans is one of the most effective ways to restore coverage, maintain 340B prescription eligibility, and secure a stable funding base.
That’s where American Exchange’s Premium Insurance Assistance Program (PIAP) comes in.
How PIAP Helps Covered Entities Protect 340B Revenue
Our Premium Insurance Assistance Program (PIAP) is a turnkey solution that helps safety-net providers identify, enroll, and support eligible patients in ACA plans—ensuring patients remain covered and eligible prescriptions continue to flow through the 340B program.
What PIAP Includes:
-
Patient Identification
We find and flag uninsured, underinsured, and recently disenrolled patients eligible for ACA coverage. -
ACA Plan Enrollment
Our expert team manages the application, eligibility verification, and plan selection processes for your patients. -
Monthly Premium Payments
PIAP includes full premium payment administration, reducing the risk of lapses and ensuring continuity of coverage. -
Real-Time Tracking via IBMS
Our proprietary, HIPAA-compliant Integrated Benefit Management System (IBMS) tracks enrollments, payments, and eligibility to support 340B compliance and reporting. -
Revenue Sustainability
When prescriptions are filled under ACA coverage, you retain 340B eligibility and generate compliant, audit-ready savings.
Why It Matters
Without patient coverage:
-
340B prescriptions are lost
-
Out-of-pocket costs increase
-
Mission-based services are underfunded
-
Financial sustainability is compromised
With PIAP, you regain control over this process—replacing uncertainty with strategy.
The Path Forward
The 340B program isn’t going away, but it’s changing. Covered entities must modernize how they capture and protect 340B savings. That starts by turning uninsured patients into insured ones—and using ACA enrollments to preserve 340B eligibility the right way.
At American Exchange, we provide the technology, expertise, and compliance infrastructure you need to succeed.
Let’s talk about building your 340B sustainability strategy.
Visit our site to schedule a strategy demo
